ARBUTUS BIOPHARMA CORP shareholders Q3 2023

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

ARBUTUS BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Assenagon Asset Management S.A. 817,574$1,659,6750.01%
OSAIC HOLDINGS, INC. 1,368,039$2,777,1190.00%
China Universal Asset Management Co., Ltd. 4,296$90.00%
MILLENNIUM MANAGEMENT LLC 1,583,572$3,214,6510.00%
Citadel Advisors 2,018,177$4,096,9000.00%
Tower Research Capital LLC (TRC) 9,509$19,3040.00%
Ameritas Investment Partners, Inc. 9,124$18,5220.00%
MORGAN STANLEY 5,261,130$10,680,0930.00%
LMR Partners LLP 57,333$116,3860.00%
Cutler Group LLC / CA 4,500$90.00%
BlackRock Inc. 10,274,141$20,856,5060.00%
GEODE CAPITAL MANAGEMENT, LLC 2,697,084$5,475,7470.00%
BNP PARIBAS FINANCIAL MARKETS 242,300$491,8690.00%
BUCKINGHAM STRATEGIC WEALTH, LLC 17,720$35,9720.00%
AMERICAN INTERNATIONAL GROUP, INC. 62,292$126,4530.00%
MONETA GROUP INVESTMENT ADVISORS LLC 23,000$46,6900.00%
MetLife Investment Management, LLC 58,981$119,7310.00%
METROPOLITAN LIFE INSURANCE CO/NY 6,209$12,6040.00%
SG Americas Securities, LLC 40,055$810.00%
RHUMBLINE ADVISERS 168,232$341,5010.00%
External links

This page lists ARBUTUS BIOPHARMA CORP's shareholders in Q3 2023. To view ARBUTUS BIOPHARMA CORP's shareholder history, click here.